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Importance 
Viral hemorrhagic fevers (VHFs) are a group of infectious diseases with similar 
symptoms in people; the causative viruses affect the vascular system and can produce 
a severe multisystemic illness in some patients. Arenaviruses known to cause VHF 
include Lassa virus (Lassa fever), Junin virus (Argentine hemorrhagic fever), 
Machupo and Chapare viruses (Bolivian hemorrhagic fever), Guanarito virus 
(Venezuelan hemorrhagic fever), Sabia virus and Lujo virus. Some of the causative 
arenaviruses have probably not been identified yet; the South American arenaviruses 
emerged as agents of VHF within the last 60 years, and Lujo virus was discovered in 
Africa in 2008.  
Arenavirus-associated VHFs are zoonotic diseases, with humans acting as 
accidental hosts. The viruses are carried in asymptomatic animal reservoirs, typically 
rodents. Nonhuman primates can be experimentally infected, but there is no evidence 
that these viruses are pathogenic in livestock, cats or dogs. In humans, the illness may 
be mild to severe or fatal. Bleeding tendencies, which are not usually life-threatening, 
occur in a proportion of the serious cases. The mortality rate for some VHFs may be 
as high as 30%. VHFs can be difficult to diagnose, particularly in the early stages 
when treatment is most effective. There are also fears that arenaviruses could be 
weaponized and used in bioterrorism. 
Etiology 
VHFs can be caused by viruses in the families Filoviridae, Arenaviridae, 
Bunyaviridae and Flaviviridae. There are more than 20 recognized members of the 
Arenaviridae, but fewer than half of these viruses have been linked to human illness. 
Arenaviruses that are known to cause viral hemorrhagic fever include Lassa virus 
(Lassa fever), Junin virus (Argentine hemorrhagic fever), Machupo and Chapare 
viruses (Bolivian hemorrhagic fever), Guanarito virus (Venezuelan hemorrhagic 
fever) and Sabia virus, as well as a recently discovered virus in Africa, which has 
been provisionally named Lujo virus. Junin, Machupo, Chapare, Guanarito and Sabia 
viruses are all found in South America, and the diseases they cause are known 
collectively as the South American hemorrhagic fevers. Whether other arenaviruses 
found in rodents can cause VHF is unknown. Flexal virus in South America, and 
Tacaribe virus in the Caribbean have each caused one or two non-fatal febrile 
illnesses in laboratory workers. Whitewater Arroyo virus has been linked to two fatal 
cases of hemorrhagic fever in California.  
Taxonomy 
The family Arenaviridae contains a single genus, Arenavirus. This genus is 
divided into two groups: the Tacaribe serocomplex and the Lassa-Lymphocytic 
choriomeningitis serocomplex. The Lassa-Lymphocytic choriomeningitis 
serocomplex, which is also called the Old World complex, contains Lassa virus and 
Lujo virus, which cause VHF in Africa. Other viruses in this complex include 
lymphocytic choriomeningitis virus (LCMV; see related factsheet), which is a human 
pathogen but does not cause hemorrhagic fever, as well as some African viruses that 
have not been linked to human disease, such as Ippy virus, Mobala virus, Mopeia 
virus, Morogoro virus and Merino Walk virus. 
The Tacaribe serocomplex, which is also called the New World complex, 
contains arenaviruses that are endemic in the Western Hemisphere. There are three or 
four clades within this complex. Clade A contains Pirital, Pichinde, Flexal, Parana 
and Allpahuayo viruses. Junin, Machupo, Guanarito, Amapari, Tacaribe, Sabia, 
Cupixi and Chapare viruses are found in clade B, while clade C contains Oliveros, 
Latino and Pinhal virus. A fourth cluster, called A/Rec, consists of a group of North 
American arenaviruses that have genetic similarities to more than one clade; their 
taxonomic position is unresolved. The currently recognized viruses in A/Rec are 
Whitewater Arroyo, Tamiami, Bear Canyon, Skinner Tank, Catarina, Tonto Creek 
and Big Brushy Tank viruses. The most important Tacaribe serocomplex viruses, in 
terms of human disease, belong to clade B. This clade also contains some viruses that 
have not been linked to human illness. 
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Geographic Distribution 
Each arenavirus is maintained in one or a few animal 
reservoir hosts, and is limited by the distribution of that 
host. The occurrence of these viruses is patchy, with higher 
infection rates among the rodents in “hot spots.” For 
example, the rodent host for Lassa virus is widespread in 
sub-Saharan Africa, but Lassa fever has been reported only 
from West Africa. This disease has been documented 
mainly in Nigeria, Liberia, Guinea and Sierra Leone, with 
isolated cases or serological evidence of the virus’s 
presence in some other West African countries. Lujo virus 
was isolated recently from a cluster of hemorrhagic fever 
cases in southern Africa. The index case became infected in 
Zambia, and transmitted the infection to medical personnel 
in Zambia and South Africa.  
In South America, viral hemorrhagic fever is caused by 
Junin virus in central Argentina, Machupo and Chapare 
viruses in Bolivia, Guanarito virus in western Venezuela, 
and Sabia virus in Brazil. In each case, the disease tends to 
occur in a limited region of the country.  
Other arenaviruses 
Old World arenaviruses that are found in rodents and 
have not been linked to human illness include Ippy virus 
and Mobala virus in the Central African Republic, Merino 
Walk virus in South Africa, Morogoro virus in Tanzania, 
and Mopeia virus in Mozambique and Zimbabwe. Serology 
suggests that Mopeia virus might also occur in the Central 
African Republic. 
A number of Tacaribe serocomplex arenaviruses have 
been isolated from South American rodents. They include 
Amapari virus, Cupixi virus and Flexal virus in Brazil, 
Oliveros virus in Argentina, Latino virus in Bolivia, Pirital 
virus in Venezuela, Pichinde virus in Colombia, Parana 
virus in Paraguay, and Allpahuayo virus in Peru. Tacaribe 
virus occurs on Trinidad in the Caribbean. Although a 
number of arenaviruses have been isolated in North 
America, only Whitewater Arroyo virus in California has 
been characterized as a possible VHF pathogen. 
Arenaviruses that cause viral hemorrhagic fever have not 
been detected in Eurasia. 
Transmission 
Rodents become chronically infected with 
arenaviruses, and can shed these viruses for a lifetime. The 
viruses can be found in many secretions and excretions 
including urine, saliva and respiratory secretions. How they 
are transmitted between rodents is incompletely understood. 
Vertical transmission of Lassa virus is thought to be 
important in its reservoir host, Mastomys natalensis; young 
mice might become infected either transplacentally or soon 
after birth. A recent epidemiological study suggests that 
horizontal transmission might also be significant in these 
rodents. Horizontal transmission is thought to be important 
in maintaining Junin virus in rodent populations. 
Arenaviruses might be spread between animals during 
various forms of close contact such as fighting, 
allogrooming, mating or huddling, or from environmental 
contamination via aerosols. In one experiment, there was no 
evidence that fetuses became infected with Junin virus in 
utero; however, half of the pups from infected dams carried 
the virus by the time they were weaned. 
Humans can be infected when arenaviruses contact 
mucous membranes or broken skin. This may occur during 
direct contact with rodents, including bites, or by indirect 
contact such as the inhalation of aerosolized excretions and 
secretions, or contact with contaminated food. Rodent urine 
is often thought to be the source of the virus. In parts of 
Africa, the rodent host for Lassa virus frequently invades 
homes. This rodent can also be part of the diet, and humans 
may become infected when they hunt the mice or prepare 
them to cook. Agricultural activities have been linked to 
infections with some South American arenaviruses. Junin 
virus infections (Argentine hemorrhagic fever), for 
example, peak during the corn harvest, when workers may 
be exposed to aerosolized virus from harvesting machinery. 
Aerosols generated during virus manipulation are often 
implicated in laboratories. Person-to-person transmission of 
arenaviruses can occur during close contact (e.g., between 
family members), and in the hospital setting when barrier 
nursing techniques are not used. The risk is particularly 
high when improperly sterilized needles are used for 
multiple patients, or when there is a safety breach, 
especially a scalpel cut, during an autopsy. Humans can 
shed arenaviruses in many body secretions and excretions 
including blood, urine, feces, saliva, vomitus and semen. 
Lassa virus can be found in the urine and semen for several 
weeks after the patient has recovered. Some arenavirus 
infections may have been venereally transmitted. 
Disinfection 
Arenaviruses can be inactivated by most detergents and 
disinfectants including 1% sodium hypochlorite and 2% 
glutaraldehyde, The viruses are also susceptible to 
ultraviolet light and gamma irradiation, and they can be 
inactivated by temperatures of 56°C (133°F) and by pH less 
than 5.5 or greater than 8.5. 
Infections in Humans 
Incubation Period 
Arenavirus infections become apparent in 
approximately one to three weeks. The incubation period is 
usually 6 to 14 days for Argentine hemorrhagic fever (Junin 
virus). It can be 7 to 16 days for Bolivian hemorrhagic fever 
caused by Machupo virus, and 3 to 21 days for Lassa fever. 
Exposure to very high doses of an arenavirus may result in 
an incubation period as short as 2 days. 
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Clinical Signs 
Arenaviruses may cause subclinical infections or mild 
to fatal disease. Viral hemorrhagic fevers are clinically 
similar. They begin with a prodromal period characterized 
by a nonspecific flu-like illness. Some patients recover, 
while others develop more severe symptoms that may 
include hemorrhages, edema, hypotension, circulatory 
collapse and neurological signs. Some cases are fatal. 
Lassa fever 
Lassa fever usually begins gradually, as a nonspecific 
illness with fever, malaise, headache, myalgia, anorexia and 
weakness. Gastrointestinal signs including nausea, 
vomiting, abdominal pain or tenderness, and diarrhea may 
also be seen. Light-skinned patients can have a 
maculopapular or petechial rash over the chest, face and 
arms. Other symptoms may include a sore throat (with or 
without signs of pharyngitis), arthralgia, lymphadenopathy, 
conjunctival injection, a dry cough and chest pain. Many 
patients recover after this prodromal stage, but up to 10% 
develop a more severe illness with severe prostration, 
edema (especially on the face and neck), hypotension, 
shock, hepatitis and/or multiorgan failure. Mucosal 
hemorrhages or bleeding tendencies, most often seen as 
mild oozing from the nose or mouth, occur in approximatey 
15-20% of these cases. Pleural and pericardial effusions are 
also possible late. Pregnant women often miscarry. 
Neurological signs such as confusion, disorientation, 
locomotor dysfunction, tremors, convulsions and coma are 
common in critically ill patients. The clinical picture can 
vary, and some people may not show the classical signs. 
For example, encephalopathy was the most prominent 
syndrome in one published case. Severely ill patients may 
die; the mortality rate is particularly high among pregnant 
women. Convalescence can be prolonged in patients who 
recover. Transient or permanent deafness often occurs 
during this stage, and can be seen in both mild and severe 
cases. 
In infants, Lassa fever can appear as “swollen baby 
syndrome,” which is characterized by generalized edema, 
abdominal distention and bleeding. Many affected infants 
die. Other concurrent health risks might contribute to this 
syndrome.  
Lujo virus infection 
Lujo virus was isolated from a cluster of hemorrhagic 
fever cases in southern Africa in 2008. Like other VHFs, 
the illness began with nonspecific flu-like signs such as 
fever, headache and muscle pain. The clinical signs 
worsened over the following week, and gastrointestinal 
signs (vomiting, diarrhea) and pharyngitis developed, 
followed by rapid deterioration with neurological signs, 
respiratory distress and circulatory collapse. Liver 
dysfunction and a rash were also reported. The case fatality 
rate was unusually high, with four of five cases ending in 
death.  
South American hemorrhagic fevers 
South American hemorrhagic fevers resemble Lassa 
fever, but hemorrhages and neurological signs are more 
likely to be seen in severe cases. The initial symptoms may 
include fever, headache, anorexia, malaise and myalgia, 
with pain especially in the lower back. Nausea or dizziness, 
abdominal pain, vomiting, diarrhea, sore throat, 
hyperesthesia of the skin, flushing of the head and torso, 
and lymphadenopathy can also be seen. Most patients 
improve after a week or two, but approximately one-third of 
untreated cases become severe and life-threatening. 
Bleeding tendencies can occur in some of these cases. 
Petechiae may be seen on the skin, and the gums may bleed 
spontaneously or with slight pressure. Hemorrhages from 
the vagina or gastrointestinal tract are also possible. Blood 
loss is usually minor, but capillary leak syndrome can lead 
to hypotension and hypovolemic clinical shock. 
Neurological signs may be the predominant syndrome in 
some patients, and death can occur without significant 
capillary leak or hemorrhages. Secondary bacterial 
infections may result in pneumonia and septicemia. 
Although convalescence can take one to three months, 
survivors usually recover completely. Temporary hair loss 
may occur due to the high fever.  
Only minor differences in clinical signs have been 
reported between the South American arenaviruses. 
Pharyngitis, vomiting and diarrhea were reported to be 
more common in patients infected with Guanarito virus, 
while erythema, petechiae, facial edema and shock may be 
seen more often in patients infected with Junin or Machupo 
viruses. Approximately 10% of Argentine hemorrhagic 
fever patients that are treated with immune plasma develop 
a late onset neurological syndrome after a symptom-free 
period. This syndrome is characterized by fever, cerebellar 
signs, cranial nerve palsies and/or other CNS signs. Its 
cause is not known. 
Infections with other arenaviruses 
Very little is known about the effects of infection with 
many arenaviruses. Three fatal illnesses were attributed to 
possible Whitewater Arroyo virus infection in California in 
1999 and 2000. Further laboratory testing from one patient, 
who had positive PCR results alone, did not confirm the 
diagnosis; however, Whitewater Arroyo virus-associated 
VHF remains a possibility in the other two cases. The 
clinical signs were similar in all three patients: an initial, 
non-specific febrile illness with headache and myalgia was 
followed by acute respiratory distress syndrome. 
Thrombocytopenia, liver failure and hemorrhagic signs 
were also seen. Febrile illnesses have been reported in two 
laboratory workers infected with Flexal virus, and one 
laboratory worker infected with Tacaribe virus. The person 
infected with Tacaribe virus also had mild neurological 
signs. A number of people who have been exposed to 
Pichinde virus have seroconverted, but this virus has not 
been linked to human illness.  
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Communicability 
Person-to-person transmission of arenaviruses can 
occur in blood, urine, feces, saliva, vomitus, semen and 
other secretions or excretions. Lassa virus can be detected 
in the urine and semen for several weeks after the patient 
has recovered. Clinical samples such as tissues also contain 
virus. Person-to-person transmission usually occurs only 
during close contact, or in the hospital setting when good 
barrier nursing is not used. The greatest risk is via 
parenteral transmission (e.g., on improperly sterilized 
needles). Some arenaviruses, such as Guanarito virus 
(Venezuelan hemorrhagic fever), might be transmitted 
infrequently between people. One study reported only one 
possible case of secondary transmission among 165 patients 
with this disease, although many were initially nursed in 
open wards where isolation procedures were minimal. In 
contrast, Lujo virus infected several people who cared for 
the index case, including one person who cleaned a room 
after a patient died. Arenaviruses can be carried to non-
endemic areas during the incubation period, which can be 
as long as three weeks.  
Diagnostic Tests 
Viral hemorrhagic fevers are often diagnosed by 
serology. Enzyme-linked immunosorbent assays (ELISAs), 
which can detect IgM or IgG, and indirect fluorescent 
antibody (IFA) tests can be used. A fourfold rise in the titer 
should be seen, or specific IgM should be detected. Cross-
reactions can occur between arenaviruses in these tests. In 
contrast, virus neutralization tests are highly specific, but 
these antibodies may appear too late to be useful in 
immediate diagnosis. For example, patients with Lassa 
fever do not usually develop neutralizing antibodies until 
weeks after they became ill. 
Arenaviral antigens can be detected in blood or tissues, 
using antigen-capture ELISAs. Diagnostic RT-PCR tests 
are available or have been published; however, there is 
limited clinical experience with these assays. Some PCR 
tests detect a wide range of arenaviruses, while others are 
more specific. 
Virus isolation can also be used for diagnosis if a 
biosafety level 4 laboratory is available. Arenaviruses can 
be recovered in cell cultures, particularly Vero cells. The 
presence of the virus can be confirmed with 
immunohistochemical assays or RT-PCR. Arenaviruses can 
also be isolated in laboratory rodents such as sucking mice, 
guinea pigs or newborn hamsters. 
Treatment 
Supportive treatment is used for all VHFs. Specific 
therapies are also available for some viruses. The antiviral 
drug ribavirin has been used in cases of Lassa fever; 
treatment is most effective when it is started early in the 
course of the disease. Ribavirin can significantly reduce the 
mortality rate from severe Lassa fever, but it does not 
prevent deafness. Some other arenaviruses also seem to be 
sensitive to this drug, but clinical experience is limited and 
only anecdotal reports and/or animal studies may be 
available. 
Human immune plasma is used to treat Argentine 
hemorrhagic fever (Junin virus), and plasma banks have 
been established. Treatment is most effective if it is started 
soon after the onset of the clinical signs; early treatment can 
decrease the mortality rate from 20-30% to 1-2%. Immune 
plasma might also be effective in patients with Bolivian 
hemorrhagic fever (Machupo virus); however, finding a 
source could be difficult, as relatively few cases are seen 
and there is no program to collect immune plasma.  
Prevention 
The risk of arenavirus infections can be decreased by 
avoiding contact with the reservoir host and its excretions. 
In endemic areas, food should be placed in rodent-proof 
containers to prevent contamination, and rodents should be 
discouraged from entering homes. This is particularly 
important when the reservoir host is one that will readily 
enter houses, such as Mastomys natalensis, the host for 
Lassa virus. Complete avoidance of contact with this 
common rodent can be difficult or impractical, although 
trapping may reduce populations around homes. The use of 
Mastomys spp. as a food source is not recommended. In 
South America, preventative measures may include 
replacing crops and burning areas that contain tall grasses. 
In urban locations, Bolivian hemorrhagic fever has been 
controlled with programs to trap Calomys callosus, the 
reservoir host for Machupo virus. 
Guidelines for the safe cleaning of rodent-infested 
areas in homes have been published. Particular care should 
be taken to avoid aerosolizing droppings during cleaning; 
areas should be wetted with disinfectant, and activities such 
as sweeping, dusting and vacuuming should be avoided. 
Precautions should also be taken in laboratories when 
working with rodents, particularly those captured from the 
wild. Current personal protective equipment 
recommendations should be followed. Veterinarians outside 
the endemic area should be aware of potential risks from 
exotic rodents imported as pets.  
Barrier nursing precautions, including the use of 
appropriate personal protective measures such as gloves, 
masks and gowns should be employed when caring for 
patients with VHFs. Good hygiene and appropriate 
sterilization of equipment should be practiced. The highest-
risk of transmission occurs during unprotected contact with 
body fluids or excreta from an infected person. There is a 
low risk of transmission from unprotected contact when 
exposure to body fluids is unlikely (e.g., skin to skin 
contact)  
A live attenuated vaccine is available in endemic areas 
for Argentine hemorrhagic fever (Junin virus). In animal 
studies, this vaccine also provided some protection against 
Bolivian hemorrhagic fever (Machupo virus) but not 
Venezuelan hemorrhagic fever (Guanarito virus) or VHF 
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caused by Sabia virus. No Lassa fever vaccine is licensed 
for humans, but experimental vaccines have shown promise 
in non-human primate models. Prophylaxis with ribavirin 
should be considered for people who are at high risk of 
having been infected with arenaviruses. However, it should 
be noted that this drug is teratogenic. 
Morbidity and Mortality 
VHFs may occur either as sporadic cases or in 
outbreaks. Recreational activities or occupational exposure 
(e.g., agricultural pursuits or handling of rodents) increase 
the risk of infection. Cases can also be seen after contact 
with rodents or their excretions in the home. Some 
outbreaks have been associated with nosocomial 
transmission. Health care workers who are not protected by 
barrier precautions are at an increased risk of exposure. 
Lassa fever and Lujo virus infections 
Lassa virus infections are common in West Africa; 
seroprevalence rates of 7% to 55% have been reported 
among humans. Approximately 100,000 to 300,000 Lassa 
virus infections and about 5000 deaths are estimated to 
occur each year. Because mild cases resemble other 
illnesses, and adequate medical and diagnostic facilities 
may not be available, this disease is probably 
underreported. Cases tend to be more common in February 
to April. Most Lassa virus infections are subclinical or 
characterized by a mild flu-like illness; 5-20% of cases may 
become severe. The overall case fatality rate is 1-2% for all 
patients with this disease, but 15–25% in those who have 
been hospitalized. Higher case fatality rates have also been 
reported; in some outbreaks, up to half of the patients have 
died. Lassa fever tends to be more severe in pregnant 
women, with case fatality rates up to 30-50%. There is 
evidence that some strains of Lassa virus might be more 
pathogenic than others.  
Little is known about Lujo virus, the only other 
arenavirus known to cause VHF in Africa. In the single 
known outbreak, four medical workers became infected 
after exposure to the index case or to secondary cases. The 
only survivor was a patient who was treated with ribavirin. 
South American arenaviruses  
Argentine hemorrhagic fever (Junin virus) was first 
recognized in the early 1950s. The region where this 
disease occurs has gradually been expanding, and by 1988, 
several hundred cases were being reported each year. 
Vaccination has decreased this number to fewer than 100 
cases a year. Argentine hemorrhagic fever is usually 
seasonal, with cases peaking during the fall harvest season, 
when agricultural workers are exposed in aerosols. Many 
infections have been associated with corn harvesting 
equipment. The case fatality rate is approximately 15-30% 
if specific therapy is not given, but the use of immune 
plasma can decrease this rate to 1-2%. 
Bolivian hemorrhagic fever (Machupo virus) emerged 
when new settlements were established in an area near the 
Amazon River. From 1959 to the early 1960s, more than a 
thousand cases were reported. In some towns, 18-21% of 
the inhabitants became ill, and the case fatality rate was as 
high as 18-41%. The overall case fatality rate for this 
disease is estimated to be approximately 20%. Most of the 
early infections occurred in people who worked on farms. 
Later, infections were also acquired within urban areas; C. 
callosus, the rodent host for Machupo virus, has a tendency 
to invade villages. Rodent control within affected villages 
was able to control this disease, and Bolivian hemorrhagic 
fever was not reported between 1976 and 1992. Nineteen 
cases were documented during an outbreak in the 1990s.  
Chapare virus was discovered in 2003-2004. This virus 
was recovered from a fatal case of hemorrhagic fever in 
rural Bolivia, outside the area where Machupo virus is 
endemic. Additional cases were reported from this 
outbreak, but details and laboratory confirmation were 
unavailable for most patients. 
Venezuelan hemorrhagic fever (Guanarito virus) is 
found in an agricultural area of northwestern Venezuela. 
This disease was first recognized in 1989, but sporadic 
cases probably occurred much earlier. It might have 
emerged due to increased contact with infected rodents after 
deforestation and human encroachment into rodent habitats. 
Venezuelan hemorrhagic fever is seasonal, peaking in 
November to January; approximately 200 cases have been 
confirmed. According to anecdotal reports, Guanarito virus 
might cause somewhat more severe disease than Junin or 
Machupo viruses. The case fatality rate can be as high as 
33%. 
Some Tacaribe serocomplex virus infections have been 
recognized rarely in people. Sabia virus was first isolated in 
1994, from an agricultural worker who died of the disease. 
No other naturally acquired cases, and two laboratory 
acquired cases have been reported. Whitewater Arroyo 
virus has been tentatively linked to at least two fatal 
illnesses in California in 1999 and 2000. The infected 
individuals were prevously healthy. Two symptomatic 
Flexal virus infections, and a single Tacaribe virus infection 
have been documented in laboratory workers. 
Seroconversion to Pichinde virus has been reported 
frequently, but this virus has not been linked to 
hemorrhagic fever.  
Infections in Animals 
Arenaviruses in Rodents 
With the exception of Tacaribe virus, which occurs in 
fruit-eating bats (Artibeus sp.), the reservoir hosts for the 
arenaviruses are rodents. Each virus is usually carried 
subclinically by one species. Old World arenaviruses are 
found in rodents in the subfamily Murinae and family 
Muridae, while New World arenaviruses have been 
detected in rodents from the subfamilies Sigmodontinae and 
Neotominae in the family Cricetidae. The reservoir hosts 
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for the viruses that cause VHFs are Mastomys natalensis 
(natal multimammate mouse) for Lassa virus, Calomys 
callosus (large vesper mouse) for Machupo virus, and 
Zygodontomys brevicauda (short-tailed cane mouse) for 
Guanarito virus. Calomys musculinus, the drylands vesper 
mouse or corn mouse, is the primary host for Junin virus. 
Evidence for Junin virus infections has also been reported 
in other rodents including C. laucha (small vesper mouse), 
Akodon azarae (grass field mouse) and Bolomys obscurus 
(dark field mouse), as well as in the predatory carnivore 
Galictis cuja (lesser grison, a member of the Mustelidae). 
The mammalian hosts for Chapare virus, Sabia virus and 
Lujo virus are not yet known. 
The infection rate among rodents varies between sites 
and over time. The prevalence of Junin virus in C. 
musculinus is 5-10% in areas where Argentine hemorrhagic 
fever outbreaks are seen. Outside these areas, the infection 
rate is lower or the virus is absent. Limited surveys suggest 
that the distribution of Lassa virus may also be patchy; in 
one study, the prevalence in M. natalensis was 0-9%. 
Human exposure can be influenced by the behavior of the 
reservoir host. The rodent host for Junin virus, for example, 
occurs almost exclusively along linear habitats such as 
fence lines and roadsides. In contrast, the reservoir host for 
Lassa virus is widespread. Although the latter species, M. 
natalensis, is found throughout sub-Saharan Africa, its 
population dynamics and tendency to enter houses may 
vary with the region. 
Arenaviruses can be carried lifelong in apparently 
healthy rodents; overt clinical signs have not been reported 
in naturally infected animals. Limited evidence from 
experimentally infected rodents suggests that some 
arenaviruses might affect fertility or survival. C. 
musculinus that were inoculated intranasally at birth with 
Junin virus had decreased weight gain while nursing and 
up to 60 days after inoculation. The mortality rate in these 
animals, examined 24-40 days after virus inoculation, was 
as high as 70%. They also became persistently infected 
and had fewer offspring than uninfected mice. Another 
study reported anemia, splenomegaly and decreased 
fertility in Calomys callosus that became persistently 
infected with Machupo virus, but not in animals that cleared 
the virus.  
Arenaviruses in Other Mammals 
Domesticated livestock, dogs and cats do not seem to 
be important in the epidemiology of arenavirus infections; 
however, their susceptibility to these viruses has not been 
fully investigated.  
Experimental infections with Lassa, Junin and 
Machupo viruses have been established in nonhuman 
primates. Some species that are susceptible to Lassa virus 
include baboons (Papio spp.), rhesus macaques (Macaca 
mulatta) and squirrel monkeys (Saimiri spp.). In rhesus 
monkeys inoculated with this virus, the clinical signs 
included lethargy, anorexia, constipation, fever, 
conjunctivitis and a skin rash. In two experiments, the 
mortality rate was 53-60%. In baboons, Lassa virus can 
cause an illness resembling the severe form of Lassa fever 
in humans, with fever, lethargy and hemorrhages.  
Rhesus macaques infected with Junin virus developed 
clinical signs including anorexia, lethargy, gastrointestinal 
signs and vascular phenomena similar to VHFs in humans. 
Ribavirin decreased the severity of the illness, but some 
treated animals had late onset neurological signs. 
Marmosets (Callithrix jacchus) infected with Junin virus 
had an acute illness with anemia, leukopenia and 
thrombocytopenia, with death in approximately 17–24 days. 
Immune serum treatment decreased the mortality rate in 
these animals from 100% to 25%, but late onset 
neurological signs were seen. Ribavirin also increased the 
survival rate in Junin virus-infected marmosets.  
Machupo virus infections have been established in 
rhesus macaques, Geoffroy’s tamarins (Saguinus geoffroyi), 
African green monkeys (Chlorocebus sabaeus) and 
marmosets. The clinical signs in African green monkeys, 
rhesus macaques and marmosets included anorexia, fever, 
conjunctivitis, depression, diarrhea, dehydration, shock, 
tremors, hemorrhages and an erythematous skin rash. The 
mortality rate was 80%-100%. Neurological signs such as 
tremors, nystagmus, incoordination, convulsions, muscle 
atrophy and paresis were reported in some rhesus macaques 
that survived. Whether any arenavirus infections occur 
naturally among non-human primates in endemic areas is 
unknown.  
Laboratory rodents including mice and guinea pigs 
(Cavia porcella) can also be infected with arenaviruses. An 
unnatural route such as intracerebral injection is often used. 
In guinea pigs inoculated intraperitoneally with Junin virus, 
the illness resembles Argentine hemorrhagic fever in 
humans. Some strains of this virus cause severe disease, 
with fever, weight loss, hypothermic shock, signs of 
encephalitis or paralysis, and death in up to 100% of the 
animals. Other strains seem to be much less virulent, with 
little or no weight loss, no clinical signs other than 
occasional fever, and no deaths. Machupo virus infections 
have also been reported in guinea pigs. As of 2010, 
arenavirus infections have not been seen in pet rodents; 
however, veterinarians should be aware that imported 
exotic rodents might carry these viruses asymptomatically. 
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Table 1: Selected arenaviruses and their known rodent hosts 
 
Virus  Rodent Host(s)  
Amapari Oryzomys gaeldi (rice rat); 
Neacomys guianae (bristly mouse) 
Bear Canyon Peromyscus californicus 
(California mouse) 
Catarina Neotoma micropus 
(southern plains woodrat)  
Chapare unknown 
Guanarito Zygodontomys brevicauda 
(short-tailedcane mouse) 
Ippy Arvicanthus sp.  
(Nile grass rat) 
Lassa Mastomys (Praomys)  natalensis  
(natal multimammate mouse) 
Latino Calomys callosus 
(large vesper mouse) 
Lujo unknown 
Junin Calomys musculinus 
(drylands vesper mouse or corn 
mouse); also other species 
Merino Walk Myotomis unisulcatus 
Machupo Calomys callosus  
(large vesper mouse) 
Mobala Praomys sp.  
(soft-furred rats) 
Mopeia Mastomys sp. 
(multimammate mice) 
Morogoro Mastomys sp. 
(multimammate mice) 
Virus  Rodent Host(s)  
Oliveros Bolomys sp. 
(bolo mice) 
Pinhal Calomys tener 
(delicate vesper mouse) 
Pirital Sigmodon alstoni  
(Alston's cotton rat) 
Sabia unknown 
Skinner Tank Neotoma mexicana 
(Mexican woodrat) 
Tacaribe Artibeus sp. bats  
Tamiami Sigmodon hispidus 
(hispid cotton rat) 
Whitewater Arroyo Neotoma albigula  
(white-throated wood rat). 
 
 
